导航临床环境:更新多发性骨髓瘤的诊断和预后生物标志物

Sahana Kabbathi Raghunathachar1, Kiran Pura Krishnamurthy2, Lokesh Maragowdanahalli Gopalaiah3

  • 1Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, 570015, India.

Molecular biology reports
|September 9, 2024
PubMed
概括

本综述探讨了用于诊断和预后的多发性骨髓瘤生物标志物. 了解这些标志物有助于个性化医疗,并改善这种复杂的血液癌症患者的治疗结果.